Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14252 | 716 | 41.9 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEMATOL ONCOLWINSHIP CANC | Address | 2 | 67% | 0% | 2 |
2 | MICROTUBULE ACTIVE DRUGS | Author keyword | 2 | 67% | 0% | 2 |
3 | PHARMACOLRAMMELKAMP EDUC | Address | 2 | 67% | 0% | 2 |
4 | RECH ONCOL BIOL ONCOPHARMACOL PHARM | Address | 2 | 67% | 0% | 2 |
5 | BCL 2 PHOSPHORYLATION | Author keyword | 2 | 27% | 1% | 7 |
6 | MOL BIOL CELL INFORMATNAKA KU | Address | 1 | 50% | 0% | 2 |
7 | BCL 2 SIRNA | Author keyword | 1 | 40% | 0% | 2 |
8 | G2M ARREST | Author keyword | 1 | 33% | 0% | 2 |
9 | LIVE CELL IMAGING | Address | 1 | 23% | 0% | 3 |
10 | AEZS 112 | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MICROTUBULE ACTIVE DRUGS | 2 | 67% | 0% | 2 | Search MICROTUBULE+ACTIVE+DRUGS | Search MICROTUBULE+ACTIVE+DRUGS |
2 | BCL 2 PHOSPHORYLATION | 2 | 27% | 1% | 7 | Search BCL+2+PHOSPHORYLATION | Search BCL+2+PHOSPHORYLATION |
3 | BCL 2 SIRNA | 1 | 40% | 0% | 2 | Search BCL+2+SIRNA | Search BCL+2+SIRNA |
4 | G2M ARREST | 1 | 33% | 0% | 2 | Search G2M+ARREST | Search G2M+ARREST |
5 | AEZS 112 | 1 | 50% | 0% | 1 | Search AEZS+112 | Search AEZS+112 |
6 | ANDROGEN INDEPENDENT CELL | 1 | 50% | 0% | 1 | Search ANDROGEN+INDEPENDENT+CELL | Search ANDROGEN+INDEPENDENT+CELL |
7 | ANDROGEN UNRESPONSIVE | 1 | 50% | 0% | 1 | Search ANDROGEN+UNRESPONSIVE | Search ANDROGEN+UNRESPONSIVE |
8 | APOPTOSIS AND DNA FRAGMENTATION | 1 | 50% | 0% | 1 | Search APOPTOSIS+AND+DNA+FRAGMENTATION | Search APOPTOSIS+AND+DNA+FRAGMENTATION |
9 | BACCATINIII | 1 | 50% | 0% | 1 | Search BACCATINIII | Search BACCATINIII |
10 | BAK ACTIVATION | 1 | 50% | 0% | 1 | Search BAK+ACTIVATION | Search BAK+ACTIVATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TAXOL INDUCED APOPTOSIS | 36 | 36% | 11% | 81 |
2 | MITOTIC BLOCK | 11 | 28% | 5% | 33 |
3 | PACLITAXEL INDUCED APOPTOSIS | 10 | 23% | 5% | 39 |
4 | BCL 2 PHOSPHORYLATION | 8 | 28% | 3% | 24 |
5 | STABILIZING ANTINEOPLASTIC AGENT | 6 | 71% | 1% | 5 |
6 | RAF 1 BCL 2 PHOSPHORYLATION | 6 | 47% | 1% | 9 |
7 | MONONUCLEAR PHAGOCYTE MICROTUBULES | 4 | 75% | 0% | 3 |
8 | DRUG TAXOL | 3 | 57% | 1% | 4 |
9 | SERINE 70 | 3 | 57% | 1% | 4 |
10 | LEUKEMIA CELLS U937 | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Paclitaxel-induced cell death - Where the cell cycle and apoptosis come together | 2000 | 331 | 123 | 44% |
Paclitaxel and immune system | 2009 | 29 | 94 | 37% |
Microtubule-targeted anticancer agents and apoptosis | 2003 | 264 | 196 | 19% |
Nature as a remarkable chemist: a personal story of the discovery and development of Taxol | 2014 | 4 | 12 | 33% |
Unwinding the loop of Bcl-2 phosphorylation | 2001 | 97 | 83 | 43% |
The immunological effects of taxanes | 2000 | 74 | 57 | 51% |
Molecular mechanism of antitumor activity of taxanes in lung cancer (Review) | 2005 | 42 | 121 | 36% |
Microtubule stabilizing agents: Their molecular signaling consequences and the potential for enhancement by drug combination | 2006 | 66 | 180 | 23% |
Microtubules in apoptosis induction: Are they necessary? | 2007 | 32 | 269 | 27% |
The immunophannacology of paclitaxel (Taxol (R)) docetaxel (Taxotere (R)), and related agents | 2003 | 54 | 90 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEMATOL ONCOLWINSHIP CANC | 2 | 67% | 0.3% | 2 |
2 | PHARMACOLRAMMELKAMP EDUC | 2 | 67% | 0.3% | 2 |
3 | RECH ONCOL BIOL ONCOPHARMACOL PHARM | 2 | 67% | 0.3% | 2 |
4 | MOL BIOL CELL INFORMATNAKA KU | 1 | 50% | 0.3% | 2 |
5 | LIVE CELL IMAGING | 1 | 23% | 0.4% | 3 |
6 | BIOL MICROBIOL IMMUNOL SECT | 1 | 50% | 0.1% | 1 |
7 | DEPARMENT CHEM BIOCHEM | 1 | 50% | 0.1% | 1 |
8 | DIMES BIOCHEM SECT | 1 | 50% | 0.1% | 1 |
9 | HEPATOBILIARY PANCREAS SURG ISLET CELL TR | 1 | 50% | 0.1% | 1 |
10 | HPUP 1833 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000123027 | REVERSINE//MITOTIC CATASTROPHE//WP 631 |
2 | 0.0000116953 | NAB PACLITAXEL//CREMOPHOR EL//NEW MAT BIOL |
3 | 0.0000082917 | UNITE BIOTECHNOL BIOINGN//RECHUNITE BIOTECHNOL BIOINGN//COLCHICINE BINDING SITE LIGANDS |
4 | 0.0000082715 | TAXACEAE//TAXOIDS//TAXOID |
5 | 0.0000081248 | EPOTHILONES//EPOTHILONE//IXABEPILONE |
6 | 0.0000080983 | PARAPTOSIS//BAP31//MEMBRANE BLEBS |
7 | 0.0000078404 | BCL 2//BCL 2 PROTEIN//BCL X |
8 | 0.0000071724 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
9 | 0.0000070706 | TUBULIN ISOTYPES//TYROSINATION//DETYROSINATION |
10 | 0.0000069533 | COMBRETASTATIN//COMBRETASTATIN A 4//COMBRETASTATINS |